New analgesic drugs derived from phencyclidine

Area of Science:

• Medicinal Chemistry
• Pharmacology

Background:

• Phencyclidine (PCP) derivatives are explored for potential therapeutic applications.
• Analgesic properties of novel compounds are of significant interest in pain management research.

Purpose of the Study:

• To synthesize and characterize novel esters derived from phencyclidine.
• To evaluate the analgesic and antinociceptive activities of these new compounds in preclinical models.

Main Methods:

• Synthesis of several esters of 1-(1-phenylcyclohexyl)-4-piperidinol, 1-(1-phenylcyclohexyl)-4-phenyl-4-piperidinol, and 1-(1-phenylcyclohexyl)-4-phenylpiperidine.
• Assessment of analgesic activity in mice using established pain models.
• Evaluation of antinociceptive activity using the mouse vas deferens bioassay.
• Reversal studies with naloxone to determine opioid receptor involvement.

Main Results:

• Several novel phencyclidine derivatives were successfully prepared and characterized.
• Compound 10, a derivative of 1-(1-phenylcyclohexyl)-4-phenyl-4-piperidinol, demonstrated potent analgesic activity, twice that of morphine.
• The antinociceptive effects of compounds 10, 11, and 13 showed a strong correlation with their activity in the mouse vas deferens assay.
• Naloxone completely reversed the observed antinociceptive effects, indicating opioid receptor mediation.

Conclusions:

• Novel phencyclidine esters possess significant analgesic properties.
• Compound 10 represents a highly potent analgesic candidate.
• The mechanism of action for these compounds involves opioid receptors.